IBA – TRANSPARENCY NOTIFICATION

(Article 14, paragraph 1 of the law of 2 May 2007 on the disclosure of major holdings)

Louvain-la-Neuve, Belgium, January 12, 2026 10:30 PM

Summary of the notification

IBA (Ion Beam Applications), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on January 6, 2026.

In its notification, Axxion S.A. indicated that it exceeded the 1% threshold on January 1, 2026 following an acquisition or disposal of securities or voting rights.

Content of the notification

• Reason for the notification: Acquisition or disposal of voting securities or voting rights, and upward crossing of the lowest threshold
• Notification by: A person who notifies alone
• Persons subject to the notification requirement:

Name	Address (for legal entities)
Axxion S.A.	15, rue de Flaxweiler, 6776 Grevenmacher, Luxembourg

• Date on which the threshold is crossed: 01-01-2026
• Threshold crossed (in %) : 1%
• Denominator : 40.514.619
• Notified details: (extract of the received notification form)

A) Voting rights	Previous notification	After the transaction
	# of voting rights	# of voting rights		% of voting rights
Holders of voting rights		Linked to securities	Not linked to the securities	Linked to securities	Not linked to the securities
Axxion S.A.		632.728	0	1.56%	0,00%
Subtotal		632.728	0	1.56%	0,00%
TOTAL		632.728	0	1.56%	0,00%

B) Equivalent financial instruments	After the transaction
Holders of equivalent financial instruments	Type of financial instrument	Expiration date	Exercise period or date	# of voting rights that may be acquired if the instrument is exercised	% of voting rights	Settlement
TOTAL

TOTAL (A & B)	# of voting rights	% of voting rights
	632.728	1.56%

• Full chain of controlled undertakings through which the holding is effectively held

         Axxion S.A. is not controlled.

About IBA
IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as one of the most advanced forms of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
For further information, please contact:

Elena De Landy
Paralegal: Corporate Affairs and Insurance 
legal@iba-group.com

Attachment

• 12012026-IBA-AxxionSA-transparencyEN